Industry: Medical Devices & Consumables
Published Date: 2025-11-02
Pages: 221 Pages
Report ld: 5344284
Request Sample
Customized Report
COVID-19 Antigen Rapid Test Cassette Market Size(US$)

CAGR 2025-2031
-20.1%
Market Size,2031
USD 5,376
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global COVID-19 Antigen Rapid Test Cassette market is projected to grow from US$ 25220 million in 2024 to US$ 5376 million by 2031, at a CAGR of -20.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
COVID-19 Antigen Rapid Test Cassette is an in-vitro immunochromatographic assay for the qualitative detection of SARS-CoV-2 viral nucleoprotein antigens in Fluorescence Immunochromatography, Colloidal Gold Immunochromatography and Latex Immunochromatography specimens from individuals suspected of COVID-19 by their healthcare provider.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
COVID-19 Antigen Rapid Test Cassette leading manufacturers including Abbott, Quidel, ACCESS BIO, CTK Biotech, SD Biosensor, Ellume, InBios, Celltrion, AESKU.GROUP, ROCHE, etc., dominate supply; the top five capture approximately % of global revenue, with Abbott leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global COVID-19 Antigen Rapid Test Cassette market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the COVID-19 Antigen Rapid Test Cassette study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to COVID-19 Antigen Rapid Test Cassette: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global COVID-19 Antigen Rapid Test Cassette Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Fluorescence Immunochromatography
1.2.3 Colloidal Gold Immunochromatography
1.2.4 Latex Immunochromatography
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global COVID-19 Antigen Rapid Test Cassette Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Home
1.3.4 School
1.3.5 Third-Party Detection Institution
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global COVID-19 Antigen Rapid Test Cassette Revenue Estimates and Forecasts 2020-2031
2.2 Global COVID-19 Antigen Rapid Test Cassette Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global COVID-19 Antigen Rapid Test Cassette Sales Estimates and Forecasts 2020-2031
2.4 Global COVID-19 Antigen Rapid Test Cassette Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global COVID-19 Antigen Rapid Test Cassette Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global COVID-19 Antigen Rapid Test Cassette Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Fluorescence Immunochromatography Market Size by Manufacturers
3.5.2 Colloidal Gold Immunochromatography Market Size by Manufacturers
3.5.3 Latex Immunochromatography Market Size by Manufacturers
3.5.4 Others Market Size by Manufacturers
3.6 Global COVID-19 Antigen Rapid Test Cassette Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global COVID-19 Antigen Rapid Test Cassette Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global COVID-19 Antigen Rapid Test Cassette Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global COVID-19 Antigen Rapid Test Cassette Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global COVID-19 Antigen Rapid Test Cassette Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America COVID-19 Antigen Rapid Test Cassette Sales and Revenue by Type (2020-2031)
6.4 North America COVID-19 Antigen Rapid Test Cassette Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America COVID-19 Antigen Rapid Test Cassette Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe COVID-19 Antigen Rapid Test Cassette Sales and Revenue by Type (2020-2031)
7.4 Europe COVID-19 Antigen Rapid Test Cassette Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe COVID-19 Antigen Rapid Test Cassette Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific COVID-19 Antigen Rapid Test Cassette Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific COVID-19 Antigen Rapid Test Cassette Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific COVID-19 Antigen Rapid Test Cassette Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America COVID-19 Antigen Rapid Test Cassette Sales and Revenue by Type (2020-2031)
9.4 Central and South America COVID-19 Antigen Rapid Test Cassette Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America COVID-19 Antigen Rapid Test Cassette Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa COVID-19 Antigen Rapid Test Cassette Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa COVID-19 Antigen Rapid Test Cassette Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa COVID-19 Antigen Rapid Test Cassette Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Abbott
11.1.1 Abbott Corporation Information
11.1.2 Abbott Business Overview
11.1.3 Abbott COVID-19 Antigen Rapid Test Cassette Product Models, Descriptions and Specifications
11.1.4 Abbott COVID-19 Antigen Rapid Test Cassette Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Abbott COVID-19 Antigen Rapid Test Cassette Sales by Product in 2024
11.1.6 Abbott COVID-19 Antigen Rapid Test Cassette Sales by Application in 2024
11.1.7 Abbott COVID-19 Antigen Rapid Test Cassette Sales by Geographic Area in 2024
11.1.8 Abbott COVID-19 Antigen Rapid Test Cassette SWOT Analysis
11.1.9 Abbott Recent Developments
11.2 Quidel
11.2.1 Quidel Corporation Information
11.2.2 Quidel Business Overview
11.2.3 Quidel COVID-19 Antigen Rapid Test Cassette Product Models, Descriptions and Specifications
11.2.4 Quidel COVID-19 Antigen Rapid Test Cassette Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Quidel COVID-19 Antigen Rapid Test Cassette Sales by Product in 2024
11.2.6 Quidel COVID-19 Antigen Rapid Test Cassette Sales by Application in 2024
11.2.7 Quidel COVID-19 Antigen Rapid Test Cassette Sales by Geographic Area in 2024
11.2.8 Quidel COVID-19 Antigen Rapid Test Cassette SWOT Analysis
11.2.9 Quidel Recent Developments
11.3 ACCESS BIO
11.3.1 ACCESS BIO Corporation Information
11.3.2 ACCESS BIO Business Overview
11.3.3 ACCESS BIO COVID-19 Antigen Rapid Test Cassette Product Models, Descriptions and Specifications
11.3.4 ACCESS BIO COVID-19 Antigen Rapid Test Cassette Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 ACCESS BIO COVID-19 Antigen Rapid Test Cassette Sales by Product in 2024
11.3.6 ACCESS BIO COVID-19 Antigen Rapid Test Cassette Sales by Application in 2024
11.3.7 ACCESS BIO COVID-19 Antigen Rapid Test Cassette Sales by Geographic Area in 2024
11.3.8 ACCESS BIO COVID-19 Antigen Rapid Test Cassette SWOT Analysis
11.3.9 ACCESS BIO Recent Developments
11.4 CTK Biotech
11.4.1 CTK Biotech Corporation Information
11.4.2 CTK Biotech Business Overview
11.4.3 CTK Biotech COVID-19 Antigen Rapid Test Cassette Product Models, Descriptions and Specifications
11.4.4 CTK Biotech COVID-19 Antigen Rapid Test Cassette Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 CTK Biotech COVID-19 Antigen Rapid Test Cassette Sales by Product in 2024
11.4.6 CTK Biotech COVID-19 Antigen Rapid Test Cassette Sales by Application in 2024
11.4.7 CTK Biotech COVID-19 Antigen Rapid Test Cassette Sales by Geographic Area in 2024
11.4.8 CTK Biotech COVID-19 Antigen Rapid Test Cassette SWOT Analysis
11.4.9 CTK Biotech Recent Developments
11.5 SD Biosensor
11.5.1 SD Biosensor Corporation Information
11.5.2 SD Biosensor Business Overview
11.5.3 SD Biosensor COVID-19 Antigen Rapid Test Cassette Product Models, Descriptions and Specifications
11.5.4 SD Biosensor COVID-19 Antigen Rapid Test Cassette Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 SD Biosensor COVID-19 Antigen Rapid Test Cassette Sales by Product in 2024
11.5.6 SD Biosensor COVID-19 Antigen Rapid Test Cassette Sales by Application in 2024
11.5.7 SD Biosensor COVID-19 Antigen Rapid Test Cassette Sales by Geographic Area in 2024
11.5.8 SD Biosensor COVID-19 Antigen Rapid Test Cassette SWOT Analysis
11.5.9 SD Biosensor Recent Developments
11.6 Ellume
11.6.1 Ellume Corporation Information
11.6.2 Ellume Business Overview
11.6.3 Ellume COVID-19 Antigen Rapid Test Cassette Product Models, Descriptions and Specifications
11.6.4 Ellume COVID-19 Antigen Rapid Test Cassette Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Ellume Recent Developments
11.7 InBios
11.7.1 InBios Corporation Information
11.7.2 InBios Business Overview
11.7.3 InBios COVID-19 Antigen Rapid Test Cassette Product Models, Descriptions and Specifications
11.7.4 InBios COVID-19 Antigen Rapid Test Cassette Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 InBios Recent Developments
11.8 Celltrion
11.8.1 Celltrion Corporation Information
11.8.2 Celltrion Business Overview
11.8.3 Celltrion COVID-19 Antigen Rapid Test Cassette Product Models, Descriptions and Specifications
11.8.4 Celltrion COVID-19 Antigen Rapid Test Cassette Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Celltrion Recent Developments
11.9 AESKU.GROUP
11.9.1 AESKU.GROUP Corporation Information
11.9.2 AESKU.GROUP Business Overview
11.9.3 AESKU.GROUP COVID-19 Antigen Rapid Test Cassette Product Models, Descriptions and Specifications
11.9.4 AESKU.GROUP COVID-19 Antigen Rapid Test Cassette Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 AESKU.GROUP Recent Developments
11.10 ROCHE
11.10.1 ROCHE Corporation Information
11.10.2 ROCHE Business Overview
11.10.3 ROCHE COVID-19 Antigen Rapid Test Cassette Product Models, Descriptions and Specifications
11.10.4 ROCHE COVID-19 Antigen Rapid Test Cassette Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 ROCHE Recent Developments
11.11 BD
11.11.1 BD Corporation Information
11.11.2 BD Business Overview
11.11.3 BD COVID-19 Antigen Rapid Test Cassette Product Models, Descriptions and Specifications
11.11.4 BD COVID-19 Antigen Rapid Test Cassette Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 BD Recent Developments
11.12 OraSure Technologies
11.12.1 OraSure Technologies Corporation Information
11.12.2 OraSure Technologies Business Overview
11.12.3 OraSure Technologies COVID-19 Antigen Rapid Test Cassette Product Models, Descriptions and Specifications
11.12.4 OraSure Technologies COVID-19 Antigen Rapid Test Cassette Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 OraSure Technologies Recent Developments
11.13 Clip Health
11.13.1 Clip Health Corporation Information
11.13.2 Clip Health Business Overview
11.13.3 Clip Health COVID-19 Antigen Rapid Test Cassette Product Models, Descriptions and Specifications
11.13.4 Clip Health COVID-19 Antigen Rapid Test Cassette Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Clip Health Recent Developments
11.14 LumiraDx
11.14.1 LumiraDx Corporation Information
11.14.2 LumiraDx Business Overview
11.14.3 LumiraDx COVID-19 Antigen Rapid Test Cassette Product Models, Descriptions and Specifications
11.14.4 LumiraDx COVID-19 Antigen Rapid Test Cassette Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 LumiraDx Recent Developments
11.15 Princeton BioMeditech Corporation
11.15.1 Princeton BioMeditech Corporation Corporation Information
11.15.2 Princeton BioMeditech Corporation Business Overview
11.15.3 Princeton BioMeditech Corporation COVID-19 Antigen Rapid Test Cassette Product Models, Descriptions and Specifications
11.15.4 Princeton BioMeditech Corporation COVID-19 Antigen Rapid Test Cassette Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Princeton BioMeditech Corporation Recent Developments
11.16 RapiGEN Inc.
11.16.1 RapiGEN Inc. Corporation Information
11.16.2 RapiGEN Inc. Business Overview
11.16.3 RapiGEN Inc. COVID-19 Antigen Rapid Test Cassette Product Models, Descriptions and Specifications
11.16.4 RapiGEN Inc. COVID-19 Antigen Rapid Test Cassette Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 RapiGEN Inc. Recent Developments
11.17 Orient Gene
11.17.1 Orient Gene Corporation Information
11.17.2 Orient Gene Business Overview
11.17.3 Orient Gene COVID-19 Antigen Rapid Test Cassette Product Models, Descriptions and Specifications
11.17.4 Orient Gene COVID-19 Antigen Rapid Test Cassette Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.5 Orient Gene Recent Developments
11.18 Wondfo Biotech
11.18.1 Wondfo Biotech Corporation Information
11.18.2 Wondfo Biotech Business Overview
11.18.3 Wondfo Biotech COVID-19 Antigen Rapid Test Cassette Product Models, Descriptions and Specifications
11.18.4 Wondfo Biotech COVID-19 Antigen Rapid Test Cassette Sales, Price, Revenue and Gross Margin (2020-2025)
11.18.5 Wondfo Biotech Recent Developments
11.19 Ihealth (Andon Health)
11.19.1 Ihealth (Andon Health) Corporation Information
11.19.2 Ihealth (Andon Health) Business Overview
11.19.3 Ihealth (Andon Health) COVID-19 Antigen Rapid Test Cassette Product Models, Descriptions and Specifications
11.19.4 Ihealth (Andon Health) COVID-19 Antigen Rapid Test Cassette Sales, Price, Revenue and Gross Margin (2020-2025)
11.19.5 Ihealth (Andon Health) Recent Developments
11.20 Wantai BioPharm
11.20.1 Wantai BioPharm Corporation Information
11.20.2 Wantai BioPharm Business Overview
11.20.3 Wantai BioPharm COVID-19 Antigen Rapid Test Cassette Product Models, Descriptions and Specifications
11.20.4 Wantai BioPharm COVID-19 Antigen Rapid Test Cassette Sales, Price, Revenue and Gross Margin (2020-2025)
11.20.5 Wantai BioPharm Recent Developments
11.21 Biotest Biotech
11.21.1 Biotest Biotech Corporation Information
11.21.2 Biotest Biotech Business Overview
11.21.3 Biotest Biotech COVID-19 Antigen Rapid Test Cassette Product Models, Descriptions and Specifications
11.21.4 Biotest Biotech COVID-19 Antigen Rapid Test Cassette Sales, Price, Revenue and Gross Margin (2020-2025)
11.21.5 Biotest Biotech Recent Developments
11.22 Shenzhen YHLO Biotech
11.22.1 Shenzhen YHLO Biotech Corporation Information
11.22.2 Shenzhen YHLO Biotech Business Overview
11.22.3 Shenzhen YHLO Biotech COVID-19 Antigen Rapid Test Cassette Product Models, Descriptions and Specifications
11.22.4 Shenzhen YHLO Biotech COVID-19 Antigen Rapid Test Cassette Sales, Price, Revenue and Gross Margin (2020-2025)
11.22.5 Shenzhen YHLO Biotech Recent Developments
11.23 Vazyme Biotech
11.23.1 Vazyme Biotech Corporation Information
11.23.2 Vazyme Biotech Business Overview
11.23.3 Vazyme Biotech COVID-19 Antigen Rapid Test Cassette Product Models, Descriptions and Specifications
11.23.4 Vazyme Biotech COVID-19 Antigen Rapid Test Cassette Sales, Price, Revenue and Gross Margin (2020-2025)
11.23.5 Vazyme Biotech Recent Developments
11.24 EasyDiagnosis Biomedicine
11.24.1 EasyDiagnosis Biomedicine Corporation Information
11.24.2 EasyDiagnosis Biomedicine Business Overview
11.24.3 EasyDiagnosis Biomedicine COVID-19 Antigen Rapid Test Cassette Product Models, Descriptions and Specifications
11.24.4 EasyDiagnosis Biomedicine COVID-19 Antigen Rapid Test Cassette Sales, Price, Revenue and Gross Margin (2020-2025)
11.24.5 EasyDiagnosis Biomedicine Recent Developments
11.25 Beijing Hotgen Biotech
11.25.1 Beijing Hotgen Biotech Corporation Information
11.25.2 Beijing Hotgen Biotech Business Overview
11.25.3 Beijing Hotgen Biotech COVID-19 Antigen Rapid Test Cassette Product Models, Descriptions and Specifications
11.25.4 Beijing Hotgen Biotech COVID-19 Antigen Rapid Test Cassette Sales, Price, Revenue and Gross Margin (2020-2025)
11.25.5 Beijing Hotgen Biotech Recent Developments
11.26 Assure Tech
11.26.1 Assure Tech Corporation Information
11.26.2 Assure Tech Business Overview
11.26.3 Assure Tech COVID-19 Antigen Rapid Test Cassette Product Models, Descriptions and Specifications
11.26.4 Assure Tech COVID-19 Antigen Rapid Test Cassette Sales, Price, Revenue and Gross Margin (2020-2025)
11.26.5 Assure Tech Recent Developments
11.27 Hangzhou AllTest Biotech
11.27.1 Hangzhou AllTest Biotech Corporation Information
11.27.2 Hangzhou AllTest Biotech Business Overview
11.27.3 Hangzhou AllTest Biotech COVID-19 Antigen Rapid Test Cassette Product Models, Descriptions and Specifications
11.27.4 Hangzhou AllTest Biotech COVID-19 Antigen Rapid Test Cassette Sales, Price, Revenue and Gross Margin (2020-2025)
11.27.5 Hangzhou AllTest Biotech Recent Developments
11.28 ACON Biotech
11.28.1 ACON Biotech Corporation Information
11.28.2 ACON Biotech Business Overview
11.28.3 ACON Biotech COVID-19 Antigen Rapid Test Cassette Product Models, Descriptions and Specifications
11.28.4 ACON Biotech COVID-19 Antigen Rapid Test Cassette Sales, Price, Revenue and Gross Margin (2020-2025)
11.28.5 ACON Biotech Recent Developments
11.29 BGI Genomics
11.29.1 BGI Genomics Corporation Information
11.29.2 BGI Genomics Business Overview
11.29.3 BGI Genomics COVID-19 Antigen Rapid Test Cassette Product Models, Descriptions and Specifications
11.29.4 BGI Genomics COVID-19 Antigen Rapid Test Cassette Sales, Price, Revenue and Gross Margin (2020-2025)
11.29.5 BGI Genomics Recent Developments
11.30 Lepu Medical Technology
11.30.1 Lepu Medical Technology Corporation Information
11.30.2 Lepu Medical Technology Business Overview
11.30.3 Lepu Medical Technology COVID-19 Antigen Rapid Test Cassette Product Models, Descriptions and Specifications
11.30.4 Lepu Medical Technology COVID-19 Antigen Rapid Test Cassette Sales, Price, Revenue and Gross Margin (2020-2025)
11.30.5 Lepu Medical Technology Recent Developments
11.31 Jinwofu Bioengineering Technology
11.31.1 Jinwofu Bioengineering Technology Corporation Information
11.31.2 Jinwofu Bioengineering Technology Business Overview
11.31.3 Jinwofu Bioengineering Technology COVID-19 Antigen Rapid Test Cassette Product Models, Descriptions and Specifications
11.31.4 Jinwofu Bioengineering Technology COVID-19 Antigen Rapid Test Cassette Sales, Price, Revenue and Gross Margin (2020-2025)
11.31.5 Jinwofu Bioengineering Technology Recent Developments
11.32 Phase Scientific
11.32.1 Phase Scientific Corporation Information
11.32.2 Phase Scientific Business Overview
11.32.3 Phase Scientific COVID-19 Antigen Rapid Test Cassette Product Models, Descriptions and Specifications
11.32.4 Phase Scientific COVID-19 Antigen Rapid Test Cassette Sales, Price, Revenue and Gross Margin (2020-2025)
11.32.5 Phase Scientific Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 COVID-19 Antigen Rapid Test Cassette Industry Chain
12.2 COVID-19 Antigen Rapid Test Cassette Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 COVID-19 Antigen Rapid Test Cassette Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 COVID-19 Antigen Rapid Test Cassette Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 COVID-19 Antigen Rapid Test Cassette Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global COVID-19 Antigen Rapid Test Cassette Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for COVID-19 Antigen Rapid Test Cassette was estimated to be worth US$ 20660 million in 2025 and is projected to reach US$ 4403 million, growing at a CAGR of -20.1% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 180
USD 3950.00
(Single User License)
The global COVID-19 Antigen Rapid Test Cassette market was valued at US$ 20660 million in 2025 and is anticipated to reach US$ 4403 million by 2032, at a CAGR of -20.1% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 164
USD 2900.00
(Single User License)
The global COVID-19 Antigen Rapid Test Cassette market size was US$ 25220 million in 2024 and is forecast to a readjusted size of US$ 5376 million by 2031 with a CAGR of -20.1% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 139
USD 4250.00
(Single User License)
The global market for COVID-19 Antigen Rapid Test Cassette was estimated to be worth US$ 25220 million in 2024 and is forecast to a readjusted size of US$ 5376 million by 2031 with a CAGR of -20.1% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 209
USD 3950.00
(Single User License)
The global market for COVID-19 Antigen Rapid Test Cassette was valued at US$ 25220 million in the year 2024 and is projected to reach a revised size of US$ 5376 million by 2031, growing at a CAGR of -20.1% during the forecast period.
Published Date: 2025-01-13
Pages: 129
USD 2900.00
(Single User License)
COVID-19 Antigen Rapid Test Cassette is an in-vitro immunochromatographic assay for the qualitative detection of SARS-CoV-2 viral nucleoprotein antigens in Fluorescence Immunochromatography, Colloidal Gold Immunochromatography and Latex Immunochromatography specimens from individuals suspected of COVID-19 by their healthcare provider.
Published Date: 2024-04-28
Pages: 125
USD 4900.00
(Single User License)
COVID-19 Antigen Rapid Test Cassette is an in-vitro immunochromatographic assay for the qualitative detection of SARS-CoV-2 viral nucleoprotein antigens in Fluorescence Immunochromatography, Colloidal Gold Immunochromatography and Latex Immunochromatography specimens from individuals suspected of COVID-19 by their healthcare provider.
Published Date: 2024-02-05
Pages: 109
USD 2900.00
(Single User License)
The global market for COVID-19 Antigen Rapid Test Cassette was estimated to be worth US$ 20660 million in 2025 and is projected to reach US$ 4403 million, growing at a CAGR of -20.1% from 2026 to 2032.
Published: 2026-06-16
Pages: 180
The global COVID-19 Antigen Rapid Test Cassette market was valued at US$ 20660 million in 2025 and is anticipated to reach US$ 4403 million by 2032, at a CAGR of -20.1% from 2026 to 2032.
Published: 2026-04-17
Pages: 164
The global COVID-19 Antigen Rapid Test Cassette market size was US$ 25220 million in 2024 and is forecast to a readjusted size of US$ 5376 million by 2031 with a CAGR of -20.1% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 139
The global market for COVID-19 Antigen Rapid Test Cassette was estimated to be worth US$ 25220 million in 2024 and is forecast to a readjusted size of US$ 5376 million by 2031 with a CAGR of -20.1% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 209
The global market for COVID-19 Antigen Rapid Test Cassette was valued at US$ 25220 million in the year 2024 and is projected to reach a revised size of US$ 5376 million by 2031, growing at a CAGR of -20.1% during the forecast period.
Published: 2025-01-13
Pages: 129
COVID-19 Antigen Rapid Test Cassette is an in-vitro immunochromatographic assay for the qualitative detection of SARS-CoV-2 viral nucleoprotein antigens in Fluorescence Immunochromatography, Colloidal Gold Immunochromatography and Latex Immunochromatography specimens from individuals suspected of COVID-19 by their healthcare provider.
Published: 2024-04-28
Pages: 125
COVID-19 Antigen Rapid Test Cassette is an in-vitro immunochromatographic assay for the qualitative detection of SARS-CoV-2 viral nucleoprotein antigens in Fluorescence Immunochromatography, Colloidal Gold Immunochromatography and Latex Immunochromatography specimens from individuals suspected of COVID-19 by their healthcare provider.
Published: 2024-02-05
Pages: 109
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now